Impact of antiretroviral therapy on intestinal lymphoid tissues in HIV infection

PLoS Medicine

Volumn 3, Issue 12, 2006, Pages 2188-2189

  Veazey, Ronald S ^a   Lackner, Andrew A ^a  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

CD4+ T LYMPHOCYTE; CELL COUNT; CELL LOSS; COLON; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; INTESTINE LYMPHATIC TISSUE; JEJUNUM; MUCOSAL IMMUNITY; NONHUMAN; RECTUM; SERODIAGNOSIS; SHORT SURVEY; UNSPECIFIED SIDE EFFECT; VIREMIA; ACUTE DISEASE; CROSS-SECTIONAL STUDY; DRUG EFFECT; IMMUNOLOGY; INTESTINE MUCOSA; LONGITUDINAL STUDY; LYMPHOID TISSUE; NOTE; PATHOPHYSIOLOGY;

ACUTE DISEASE; ANTI-RETROVIRAL AGENTS; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HUMANS; INTESTINAL MUCOSA; LONGITUDINAL STUDIES; LYMPHOID TISSUE;

EID: 33845864976     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030515     Document Type: Short Survey

References (7)

1. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, et al. (2004) CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200: 749-759.
2. Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, et al. (2004) Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 200: 761-770.
3. + T cell depletion and viral replication in SIV infection. Science 280: 427-431.
4. Veazey RS, Lackner AA (2005) HIV swiftly guts the immune system. Nat Med 11: 469-470.
5. Mehandru S, Poles MA, Tenner-Racz K, Jean-Pierre P, Manuelli V, et al. (2006) Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. PLoS Med 3(12): e484. doi:10.1371/journal.pmed. 0040484
6. Guadalupe M, Sankaran S, George MD, Reay E, Verhoeven D, et al. (2006) Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J Virol 80: 8236-8247.
7. + T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration. J Virol 79: 2709-2719.